期刊文献+

华法林在维持血液透析长期留置导管通畅中的作用 被引量:14

暂未订购
导出
摘要 对于糖尿病、高血压或其它原因导致血管条件不佳的终末期肾病患者来说,建立动静脉内瘘难度较大,故长期留置的中心静脉导管(Central venous catheters,TCC)成为这些患者的重要血管通路。据美国慢性肾脏病及透析的临床实践指南报道[1、血栓和纤维鞘形成是TCC功能不良的主要的并发症,也是影响导管使用寿命的主要原因,
作者 蔡晓青 刘毅
出处 《中国血液净化》 2013年第1期50-52,共3页 Chinese Journal of Blood Purification
  • 相关文献

参考文献20

  • 1National Kidney Foundation.1.NKF K/DOQI Clinical Practice Guidelines for Vascular Access:update2000[J].Am J Kidney Dis,2001,37(Suppll):S137-S181.
  • 2Suchoki P,Conion P,Knelson M,et al.Silastic cuffed catheters for hemodialysis vascular access:Thrombolytic and mechanical correction of malfunction[J].Am J Kidney Dis,1996,28:379-386.
  • 3Collins DM,Lambert MB,Middleton JP,et al.Fistula dysfunction:Effect on rapid hemodialysis[J].Kidney Int 1992,41:1292-1296.
  • 4BernMM,Lokich JJ,Wallach SR,et al.Very low doses of warfarin can prevent thrombosis in central venous catheters:A randomized prospective trial[J].Ann Intern Med 1990,112:423-428.
  • 5Boraks P,Seale J,Price J,et al.Prevention of central venous catheter associated thrombosos using minidose warfarin in patients with haematological malignancies[J].Br J Haematol 1998,101:483-486.
  • 6Mokrzycki MH,Jean-Jerome K,Rush H,et al.A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled,cuffed hemodialysis catheters[J].Kidney Int,2001,59:1935-1942.
  • 7Young AM,Billingham LJ,Begum G,et al.Warfarin thromboprophylaxis in cancer patients with central venous catheters(WARP):an open-label randomised trial[J].Lancet,2009,14,373:567-574.
  • 8Zellweger M,Bouchard J,Raymond-Carrier S,et al.Systemic Anticoagulation and Prevention of Hemodialysis Catheter Malfunction[J].ASAIO J,2005,5:360-365.
  • 9Obialo CI,Conner AC,Lebon LF:Maintaining Patency of Tunneled Hemodialysis Catheters:Efficacy of Aspirin Compared to Warfarin.Scand J Urol Nephrol,2003,37:172-176.
  • 10TJ Wilkieson,AJ Ingram,MA Crowther,et al.Low-Intensity Adjusted-Dose Warfarin for the Prevention of Hemodialysis Catheter Failure[J].A Randomized,Controlled Trial[J].Clin J Am Soc Nephrol,2011,6:1018-1024.

二级参考文献15

  • 1郭云珊,李保春,郭志勇,付鹏,许静,苏红,张国兆.Permcath导管长期并发症研究[J].中国血液净化,2007,6(7):369-372. 被引量:19
  • 2Michele HMokrzycki,Kernilde Jean-Jerome,Heather Rush et al.A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled,cuffed hemodialysis catheters[J].Kidney Int,2001,59:1935-1942.
  • 3Ibrahiem Saeed,Al-Howaish Abdulla K.Warfarin Versus Aspirin in Preventing Tunneled Hemodialysis Catheter Thrombosis:A prospective randomized study[J].Hong Kong J Nephrol,2007,9:23-30.
  • 4Quarello F,Forneris G,Borca M,et al.Do central venous catheters have advantages over arteriovenous fistulas or grafts?[J].J Nephrol,2006,19):265-279.
  • 5Naufel燚,Salazar-Bianco燝,Faintuch燬,et al.Malfunction of dialysis catheters:management of fibrin sheath and related problems[J].J Vasc Interv Radiol,2009,20:S126.
  • 6Vascular Access 2006 Work Group.Clinical practice guidelines for vascular access[J].Am J Kidney Dis,2006,48(Suppl 1):S176-247.
  • 7Suhocki PV,Conlon MJ,KnelsonMH,et al.Silastic cuffed catheters for hemodialysis vascular access:Thrombolytic and mechanical correction of malfunction[J].Am J Kidney Dis,1996,28:379-386.
  • 8CrainM.Management of catheter fibrin sheaths[J].Semin dial,1998,11:336-341.
  • 9Michele HMokrzycki,Kernilde Jean-Jerome,Heather Rush,et al.A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled,cuffed hemodialysis catheters[J].Kidney Int,2001,59:1935-1942.
  • 10Hemmelgarn BR,Moist LM,Lok CE,et al.Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator[J].N Engl J Med,2011,364:303-12.

共引文献75

同被引文献108

引证文献14

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部